Philip S. Schoenfeld
Corporate Officer/Principal bei University of Michigan Medical School
Ursprung des Netzwerks ersten Grades von Philip S. Schoenfeld
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of Michigan Medical School
5
| College/University | Other Consumer Services | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Philip S. Schoenfeld
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Michigan | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Wayne State University (Michigan) | College/University | Doctorate Degree Doctorate Degree | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Grand Valley State University (Michigan) | College/University | Undergraduate Degree | |
| THE NOW CORPORATION | Miscellaneous Commercial Services | Director/Board Member | |
| University of California San Diego | College/University | Corporate Officer/Principal | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| AVANTOR, INC. | Chemicals: Specialty | Director/Board Member | |
| University of Virginia Darden School of Business | College/University | Masters Business Admin | |
| University of California | College/University | Graduate Degree | |
| Peking University School of Pharmaceutical Sciences | College/University | Undergraduate Degree | |
| Brown University | College/University | Doctorate Degree | |
| The BayHelix Group | Corporate Officer/Principal | ||
| Peking University Health Science Center | College/University | Corporate Officer/Principal | |
| Shanghai Foundation For Rare Disease | Corporate Officer/Principal | ||
| China Alliance For Rare Diseases | Corporate Officer/Principal | ||
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Part of CANbridge Pharmaceuticals Inc., Canbridge Pharmaceuticals is a rare disease-focused biopharmaceutical company based in Cambridge, MA. Canbridge Pharmaceuticals, Inc. (United States) was established in 2012 and is committed to researching, developing, and commercializing transformative therapies for rare diseases. | Biotechnology | President | |
| CANbridge Consulting LLC | Founder | ||
CANbridge Life Sciences Ltd.
 CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of Illinois | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 17 |
| China | 7 |
| Schweden | 2 |
Sektoral
| Consumer Services | 11 |
| Health Technology | 7 |
| Commercial Services | 3 |
| Process Industries | 2 |
Operativ
| Corporate Officer/Principal | 16 |
| Founder | 4 |
| Doctorate Degree | 4 |
| President | 3 |
| Director/Board Member | 3 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Xue | 14 |
| John Carethers | 5 |
| David Krolewski | 4 |
| Michael Holinstat | 4 |
| Stephen E. Feinberg | 3 |
- Börse
- Insiders
- Philip S. Schoenfeld
- Unternehmensverbindungen
